Detalles de la búsqueda
1.
Dupilumab provides sustained effectiveness on patient-reported outcomes and favorable safety in patients with moderate-to-severe atopic dermatitis: up to 5-year results from the daily practice BioDay Registry.
J Am Acad Dermatol;
2024 Apr 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-38653344
2.
Real-world Experience of Abrocitinib Treatment in Patients with Atopic Dermatitis and Hand Eczema: Up to 28-week Results from the BioDay Registry.
Acta Derm Venereol;
104: adv19454, 2024 02 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-38323500
3.
Hand eczema-related presenteeism and sickness absence: A cross-sectional population-based study.
Contact Dermatitis;
90(4): 372-377, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38353129
4.
Validity, reliability, responsiveness and interpretability of the Recap of atopic eczema (RECAP) questionnaire.
Br J Dermatol;
189(5): 578-587, 2023 10 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-37463409
5.
Successful tapering of dupilumab in patients with atopic dermatitis with low disease activity: a large pragmatic daily practice study from the BioDay registry.
Br J Dermatol;
189(3): 327-335, 2023 08 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-37177895
6.
Beyond Anxiety and Depression: Loneliness and Psychiatric Disorders in Adults with Atopic Dermatitis.
Acta Derm Venereol;
103: adv9378, 2023 Aug 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-37605893
7.
Which outcomes should be measured in hand eczema trials? Results from patient interviews and an expert survey.
J Eur Acad Dermatol Venereol;
37(6): 1199-1206, 2023 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-36695080
8.
Experiences from daily practice of upadacitinib treatment on atopic dermatitis with a focus on hand eczema: Results from the BioDay registry.
Contact Dermatitis;
88(5): 351-362, 2023 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-36621910
9.
Patient-centered dupilumab dosing regimen leads to successful dose reduction in persistently controlled atopic dermatitis.
Allergy;
77(11): 3398-3407, 2022 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-35837880
10.
Dupilumab in daily practice for the treatment of pediatric atopic dermatitis: 28-week clinical and biomarker results from the BioDay registry.
Pediatr Allergy Immunol;
33(12): e13887, 2022 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-36564878
11.
Prevalence and Severity of Hand Eczema in the Dutch General Population: A Cross-sectional, Questionnaire Study within the Lifelines Cohort Study.
Acta Derm Venereol;
102: adv00626, 2022 Jan 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-34664079
12.
Daily Practice Experience of Baricitinib Treatment for Patients with Difficult-to-Treat Atopic Dermatitis: Results from the BioDay Registry.
Acta Derm Venereol;
102: adv00820, 2022 Nov 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-36420885
13.
Association between moderate to severe atopic dermatitis and lifestyle factors in the Dutch general population.
Clin Exp Dermatol;
47(8): 1523-1535, 2022 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-35384028
14.
Hand eczema and lifestyle factors in the Dutch general population: Evidence for smoking, chronic stress, and obesity.
Contact Dermatitis;
86(2): 80-88, 2022 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-34766356
15.
Exposure and work-related factors in subjects with hand eczema: Data from a cross-sectional questionnaire within the Lifelines Cohort Study.
Contact Dermatitis;
86(6): 493-506, 2022 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-35122264
16.
Patients' perspectives on quality of care for chronic hand eczema: A qualitative study.
Contact Dermatitis;
86(3): 204-212, 2022 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-34871458
17.
Lifestyle factors and hand eczema: A systematic review and meta-analysis of observational studies.
Contact Dermatitis;
87(3): 211-232, 2022 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-35277987
18.
European Surveillance System on Contact Allergies (ESSCA): Characteristics of patients patch tested and diagnosed with irritant contact dermatitis.
Contact Dermatitis;
2021 Mar 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-33729576
19.
Hyperkeratotic hand eczema: Eczema or not?
Contact Dermatitis;
83(3): 196-205, 2020 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-32333380
20.
Baricitinib treatment of severe chronic hand eczema: Two case reports.
Contact Dermatitis;
86(5): 419-421, 2022 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-34989004